News

FDA approves inhaled form of insulin

The U.S. Food and Drug Administration has approved a new insulin drug that will allow diabetics to set needles aside at mealtimes and use inhalers instead.

Afrezza Inhalation Powder, however, is not a substitute for long-acting insulin. The new drug is intended to be used in combination with long-acting insulin for patients with type 1 diabetes, the FDA said. However, a clinical trial showed that Afrezza was effective in treating both types of diabetes. People with type 2 diabetes can use it in combination with oral antidiabetic drugs.

Tom Wilemon

Full Story: http://www.usatoday.com/story/news/nation/2014/06/28/fda-inhaled-insulin-diabetes-afrezza/11612739/

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.